But in the realm of prostate cancer, one major development, the Gleason grading system for tumors, has stood the test of time. The man who developed the grading scale in 1966, Dr. Donald Gleason, died ...

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

“45 and 50 for routine screening, and then earlier 40 to 45 in men who have a higher risk for having prostate cancer, those ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...

Investigators created a prognostic digital pathology-based AI score to identify a subset of patients with clinically high-risk prostate cancer more likely to benefit from the addition of abiraterone ...

Prostate cancer tends to develop in older men, aged 50 and over. In many cases prostate cancer develops slowly, although in some cases it can be aggressive and metastasize to other parts of the ...

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

The firm hopes to overcome common dose-limiting toxicities with its PSMA-targeted radiotherapy while boosting potency versus competitors.